Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab

Saved in:
Bibliographic Details
Published in:Clinical, Cosmetic and Investigational Dermatology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871022076301672448
collection WordPress RSS
FRELIP Feed Integration
container_title Clinical, Cosmetic and Investigational Dermatology
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:104188
institution FRELIP
journal_source_facet Clinical, Cosmetic and Investigational Dermatology
last_indexed 2026-07-18T03:34:59.481Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_alt Terapia Biológica Personalizada para el Penfigoide Ampolloso Refractario: Omalizumab, Dupilumab y Rituximab Secuenciales
Thérapie biologique personnalisée pour la pemphigoïde bulleuse réfractaire : omalizumab, dupilumab et rituximab séquentiels
Terapia Biológica Personalizada para Penfigoide Bolhoso Refratário: Omalizumabe, Dupilumabe e Rituximabe Sequenciais
title_auth Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_es_txt Terapia Biológica Personalizada para el Penfigoide Ampolloso Refractario: Omalizumab, Dupilumab y Rituximab Secuenciales
title_fr_txt Thérapie biologique personnalisée pour la pemphigoïde bulleuse réfractaire : omalizumab, dupilumab et rituximab séquentiels
title_full Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_fullStr Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_full_unstemmed Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_pt_txt Terapia Biológica Personalizada para Penfigoide Bolhoso Refratário: Omalizumabe, Dupilumabe e Rituximabe Sequenciais
title_short Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
title_sort personalized biologic therapy for refractory bullous pemphigoid: sequential omalizumab, dupilumab, and rituximab
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://www.dovepress.com/personalized-biologic-therapy-for-refractory-bullous-pemphigoid-sequen-peer-reviewed-fulltext-article-CCID